Results 171 to 180 of about 3,734,628 (292)
Insights into the Therapeutic Use of <i>Kalanchoe pinnata</i> Supplement in Diabetes Mellitus. [PDF]
Omoruyi F +4 more
europepmc +1 more source
PICALM::MLLT10 translocated leukemia
This comprehensive review of PICALM::MLLT10 translocated acute leukemia provides an in‐depth review of the structure and function of CALM, AF10, and the fusion oncoprotein (1). The multifaceted molecular mechanisms of oncogenesis, including nucleocytoplasmic shuttling (2), epigenetic modifications (3), and disruption of endocytosis (4), are then ...
John M. Cullen +7 more
wiley +1 more source
Editorial-Translation of purinergic drugs into therapeutic use. [PDF]
Kennedy C.
europepmc +1 more source
Cell wall target fragment discovery using a low‐cost, minimal fragment library
LoCoFrag100 is a fragment library made up of 100 different compounds. Similarity between the fragments is minimized and 10 different fragments are mixed into a single cocktail, which is soaked to protein crystals. These crystals are analysed by X‐ray crystallography, revealing the binding modes of the bound fragment ligands.
Kaizhou Yan +5 more
wiley +1 more source
The Prophylactic and Therapeutic Use of the Heli-FX EndoAnchor System in Patients Undergoing Endovascular Aortic Aneurysm Repair-A Scoping Review. [PDF]
Dakis K +7 more
europepmc +1 more source
Physiological Renormalization Using Systems Therapeutics [PDF]
openaire +3 more sources
Bone metastasis in prostate cancer (PCa) patients is a clinical hurdle due to the poor understanding of the supportive bone microenvironment. Here, we identify stearoyl‐CoA desaturase (SCD) as a tumor‐promoting enzyme and potential therapeutic target in bone metastatic PCa.
Alexis Wilson +7 more
wiley +1 more source
Therapeutic Use of Integrin Signaling in Melanoma Cells: Physical Link with the Extracellular Matrix (ECM). [PDF]
Adamiak-Nikolouzou K +3 more
europepmc +1 more source
We reconstituted Synechocystis glycogen synthesis in vitro from purified enzymes and showed that two GlgA isoenzymes produce glycogen with different architectures: GlgA1 yields denser, highly branched glycogen, whereas GlgA2 synthesizes longer, less‐branched chains.
Kenric Lee +3 more
wiley +1 more source
Antimicrobial peptides: an overview of a promising class of therapeutics
Giuliani Andrea +2 more
doaj +1 more source

